Cargando…
A review on the pharmacokinetic properties and toxicity considerations for chloroquine and hydroxychloroquine to potentially treat coronavirus patients
The SARS-CoV-2 virus, caused a novel emerged coronavirus disease, is growing rapidly worldwide. Few studies have evaluated the efficacy and safety of Chloroquine (CQ), an old antimalarial drug, and Hydroxychloroquine (HCQ) in the treatment of COVID-19 infection. HCQ is derived from CQ by adding a hy...
Autores principales: | Askarian, Fatemeh, Firoozi, Zahra, Ebadollahi-Natanzi, Alireza, Bahrami, Solmaz, Rahimi, Hamid-Reza |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Singapore
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8286988/ https://www.ncbi.nlm.nih.gov/pubmed/34306523 http://dx.doi.org/10.1007/s43188-021-00101-5 |
Ejemplares similares
-
Chloroquine and Hydroxychloroquine Retinal Toxicity Consideration in the Treatment of COVID-19
por: Ruamviboonsuk, Paisan, et al.
Publicado: (2020) -
Safety considerations for chloroquine and hydroxychloroquine in the treatment of COVID-19
por: Gevers, S., et al.
Publicado: (2020) -
Brief Review of Chloroquine and Hydroxychloroquine Toxicity and Management
por: Lebin, Jacob A., et al.
Publicado: (2020) -
Aminoquinolines against coronavirus disease 2019 (COVID-19): chloroquine or hydroxychloroquine
por: Sahraei, Zahra, et al.
Publicado: (2020) -
Repurposing Drugs for COVID-19: Pharmacokinetics and Pharmacogenomics of Chloroquine and Hydroxychloroquine
por: Babayeva, Mariana, et al.
Publicado: (2020)